Table 2 Patients' characteristics at randomisation. If not otherwise stated, data is arithmetic mean and standard deviation.
Patient characteristics | Controls | Intervention |
|---|---|---|
Number of patients | 108 | 122 |
Sex (F/M) | 26/82 | 42/80 |
Age, years (range) | 70.8 (41–88) | 70.3 (34–89) |
Weight, kg | 81.8 (20.2) | 77.6 (17.3) |
Height, cm | 173.6 (8.2) | 172.0 (9.6) |
Treatment at randomisation | ||
Diuretics, n (%) | 95 (90) | 110 (90) |
ACE-inhibitors, n (%) | 85 (79) | 99 (81) |
Beta-blockers, n (%) | 46 (43) | 67 (55) |
Spironolactone, n (%) | 24 (22) | 22 (18) |
Digitalis, n (%) | 28 (26) | 54 (44)* |
Aspirin, n (%) | 36 (33) | 60 (49)* |
Blood chemistry | ||
Creatinine, μmol/L | 120.1 (43.0) | 111.4 (42.4) |
Glucose, mmol/L (median, inter-quartile range) | 5.5 (4.8–7.2) | 5.65 (4.7–6.7) |
Potassium, mmol/L | 4.0 (0.4) | 4.0 (0.4) |